![]() | ![]() |
Formats:
|
||||||||||||||||||||||||||
Copyright © 2003, American Society for Microbiology Analysis of 4.3 Kilobases of Divergent Locus B of Macaque Retroperitoneal Fibromatosis-Associated Herpesvirus Reveals a Close Similarity in Gene Sequence and Genome Organization to Kaposi's Sarcoma-Associated Herpesvirus Department of Pathobiology, School of Public Health and Community Medicine,1 National Primate Research Center, University of Washington, Seattle, Washington2 *Corresponding author. Mailing address: Department of Pathobiology, Box 357238, University of Washington, Seattle, WA 98195. Phone: (206) 616-2084. Fax: (206) 543-3873. E-mail: trose/at/u.washington.edu. †Present address: Rosetta Inpharmatics, Inc., Bothell, WA 98011. ‡Present address: Fred Hutchinson Cancer Research Center, Seattle, WA 98109. Received December 2, 2002; Accepted January 28, 2003. This article has been cited by other articles in PMC.Abstract We previously identified retroperitoneal fibromatosis-associated herpesvirus (RFHV) as a simian homolog of Kaposi's sarcoma-associated herpesvirus (KSHV) in a fibroproliferative malignancy of macaques that has similarities to Kaposi's sarcoma. In this report, we cloned 4.3 kb of divergent locus B (DL-B) flanking the DNA polymerase gene from two variants of RFHV from different species of macaque with a consensus degenerate hybrid oligonucleotide primer approach. Within the DL-B region of RFHV, viral homologs of the cellular interleukin-6, dihydrofolate reductase, and thymidylate synthase genes were identified, along with a homolog of the gammaherpesvirus open reading frame (ORF) 10. In addition, a homolog of the KSHV ORF K3, the modulator of immune recognition-1, was identified. Our data show a close similarity in sequence conservation, gene content, and genomic structure between RFHV and KSHV which strongly supports the grouping of these viral species within the same RV-1 rhadinovirus lineage and the hypothesis that RFHV is the macaque homolog of KSHV. The most recently discovered human tumor virus, Kaposi's sarcoma-associated herpesvirus (KSHV), has been implicated in the pathogenesis of Kaposi's sarcoma, primary effusion lymphoma, and Castleman's disease (for a review, see reference 41). KSHV was assigned to the Rhadinovirus genus of the gammaherpesviruses based on similarities at the levels of nucleotide sequence, gene content, and genomic structure with the Rhadinovirus prototype, Herpesvirus saimiri (HVS) of the South American squirrel monkey (30). Like other gammaherpesviruses, KSHV has numerous genes with homology to cellular host genes which have been captured during virus evolution (37). Viral homologs of cellular genes contribute to the unique biological properties and pathogenic effects of different viral species and, in the case of KSHV, function in the disruption of antiviral responses, cytokine-regulated cell growth, apoptosis, and cell cycle control (29). As in other gammaherpesviruses, these cellular homologs cluster in a restricted number of divergent genomic loci, and the presence and orientation of these genes are uniquely characteristic of KSHV. We have identified a simian homolog of KSHV in macaque retroperitoneal fibromatosis (36), a vascular fibroproliferative malignancy with morphological and histological similarities to Kaposi's sarcoma (12, 45). A consensus degenerate hybrid oligonucleotide primer (CODEHOP) technique (35) utilizing PCR primers derived from highly conserved amino acid motifs within the herpesvirus DNA polymerase genes was used to amplify DNA sequences from retroperitoneal fibromatosis lesions of two macaque species. These sequences were identified as portions of the DNA polymerase genes of two closely related novel viruses, retroperitoneal fibromatosis-associated herpesvirus of Macaca mulatta (RFHVMm) and of Macaca nemestrina (RFHVMn) (36). Subsequently, it was shown that these macaque species are also host to another closely related herpesvirus with similarity to KSHV, rhesus rhadinovirus (RRV) (11) and Macaca nemestrina rhadinovirus 2 (RV-2) (40). This virus has been alternatively named pig-tail rhadinovirus (26) and pig-tailed monkey rhadinovirus (4). Phylogenetic analysis of the DNA polymerase sequences demonstrated that RFHVMm and RFHVMn clustered together with KSHV within a lineage designated rhadinovirus 1 (RV-1), while RRV and M. nemestrina RV-2 cluster into a more distantly related lineage designated rhadinovirus 2 (RV-2) (40). Additional studies have identified viral species belonging to both the RV-1 and RV-2 lineages of KSHV-related viruses in a number of Old World primate host species, including African green monkeys, drills, mandrills, gorillas, and chimpanzees (13, 14, 20-22). Classification of viral species within the RV-1 and RV-2 rhadinovirus lineages has been based mainly on comparisons of partial sequences of DNA polymerase genes. In this report, we cloned 4.3 kb of divergent locus B (DL-B) flanking the DNA polymerase gene of RFHVMm and RFHVMn with the CODEHOP strategy. As in the corresponding DL-B locus in KSHV, viral homologs of the cellular interleukin-6 (vIL-6), dihydrofolate reductase (vDHFR), and thymidylate synthase (vTS) genes were identified, along with a homolog of the conserved gammaherpesvirus open reading frame (ORF) 10. In addition, a homolog of the KSHV ORF K3, the modulator of immune recognition-1 (MIR-1) (10), was identified. Our data show a close similarity between the nucleotide sequences, gene content, and genomic structure of RFHV and KSHV, supporting the hypothesis that these viral species belong to the same RV-1 viral lineage and that RFHV is the macaque homolog of KSHV. Genetic differences were identified between the RV-1 and RV-2 macaque viruses, suggesting important biological differences between the two rhadinovirus lineages. MATERIALS AND METHODS Tissue samples. Retroperitoneal fibromatosis tumor samples were obtained from a simian retrovirus 2-infected Maccaca mulatta (MmuYN-91) provided by Harold McClure, Yerkes National Primate Research Center, Atlanta, Ga. Retroperitoneal fibromatosis tumor and spleen samples from a simian retrovirus 2-infected M. nemestrina (Mne442N) diagnosed with retroperitoneal fibromatosis were obtained from Riri Shibata, National Institutes of Health, Bethesda, Md. DNA isolation. Frozen tissue samples were quickly thawed in the presence of a standard proteinase K extraction buffer containing 0.1% sodium dodecyl sulfate by homogenization in a disposable homogenizer. Samples were digested at 55°C for several hours, and the DNA was purified by standard phenol-chloroform extraction and ethanol precipitation. Partial inverse PCR. In order to clone the region flanking the DNA polymerase gene of RFHVMm, 5 μg of high-molecular-weight DNA extracted from a retroperitoneal fibromatosis tumor sample obtained from MmuYN-91 was partially digested with MboI (New England Biolabs) at enzyme dilutions ranging from 2 U/μg of DNA to 0.031 U/μg of DNA. Appropriately sized fragments were circularized with 4 U of T4 DNA ligase/μl (Promega) for 6 h at 22°C, essentially as described (33). PCR amplification was then performed with the DRIPA (5′-TTCACGACAGGATACCCTACG-3′) sense and QIRQB (5′-CAGCTCCTCTTGTCTGATTTG-3′) antisense primers derived from the 5′ end of the RFHVMm DNA polymerase sequence (Fig. (Fig.1),1
Thermal gradient CODEHOP PCR amplification of thymidylate synthase homolog. CODEHOPs were designed with an alignment of the vTS genes from KSHV, herpesvirus saimiri (HVS), and equine herpesvirus 2 (EHV2) (see Table 1 for accession numbers) with the method previously described (35). Two conserved amino acid sequence motifs, RHFG and DMGL, were chosen as targets. The CODEHOPs RHFGA (5′-CCTGTTTACGGTTTCCARTGGAGRCAYTTYGG-3′) and DMGLB (5′-GGCAATGTTAAAAGGAACTCCNARNCCCATRTC-3′) were derived from these motifs and designated A (sense orientation) or B (antisense orientation), where Y = C or T; R = A or G; and N = A, C, G, or T. Approximately 1 μg of DNA extracted from the retroperitoneal fibromatosis tumors of MmuYN-91 and Mne442N was used as the template in a PCR in 0.067 M Tris-HCl (pH 8.8)-4 mM MgCl2-0.016 M (NH4)2SO4-0.01 M β-mercaptoethanol-100 μg of bovine serum albumin per ml (24)-100 nM deoxynucleoside triphosphates-1 μM each oligonucleotide-2.5 U of Platinum Taq polymerase (Life Technologies) in a 50-μl reaction volume. Amplification was preceded by a 1-min incubation at 95°C to activate the polymerase. Cycling conditions consisted of a 30-s 94°C denaturing step, a 30-s 55 to 70°C annealing step, and a 30-s 72°C extension step for 40 cycles in a thermal gradient iCycler thermocycler (Bio-Rad).
Long-range PCR amplification. High-molecular-weight DNA isolated from retroperitoneal fibromatosis tissue of MmuYN-91 and spleen tissue from Mne442N was used as the template in long-range PCR amplification of the region between the ORF 10 and TS genes of RFHVMm and between the DNA polymerase and TS genes of RFHVMn. The gene-specific PCR primers F6565 (5′-TGAACTATTTTGCTACCCCAACACCGCTAT-3′; ORF 10, RFHVMm), R20432 (5′-CTTTGCCCCCCTGTCACGTTCTCTGTCAGT-3′; vTS, RFHVMm), PolF1LR 5′-CCACCGTCCCAGACCAACGAAAGCGCCAGA-3′; DNA polymerase, RFHVMn), and TSR1LR (5′-GTCTGCCTGGAATCCCGTGGATATACCAAA-3′; vTS, RFHVMn) were designed with Oligonucleotide v5 software (NBI) with a standard length of 30 nucleotides to ensure high specificity and annealing temperature (see Fig. Fig.1).1 DNA sequencing and sequence assembly. PCR products were either cloned and sequenced with vector-specific primers or sequenced directly with CODEHOP or gene-specific primers. Additional internal gene-specific primers were used to obtain overlapping sequences within the larger PCR products. Multiple PCR products and clones were sequenced in both orientations to avoid artifacts and Taq polymerase errors. Sequencing was performed on an ABI model 310 automated sequencer with Prism Big Dye terminator cycle sequencing ready reaction kit with Amplitaq DNA polymerase FS (Applied Biosystems). DNA sequences were assembled with Sequencher 4.0.5b10 (GeneCodes). Sequence redundancy was three- to fourfold. Sequence and phylogenetic analysis. ORFs were identified in Sequencher and compared to existing sequences with Blast analysis of the NCBI nonredundant database. RFHV ORFs were named according to the nomenclature proposed for KSHV (37), with ORFs not found in HVS designated with an RF preface, for example, RF3. Pairwise nucleotide and encoded amino acid alignments were performed with GenePro software (Riverside Scientific, Bainbridge Island, Wash.). Multiple sequence alignment was done with ClustalW (EMBL, Heidelberg, Germany). Phylogenetic analysis of amino acid sequences was done with parsimony, neighbor-joining analysis, and protein maximum likelihood (ProML) from the Phylip package version 3.6 of phylogenetic analysis programs (University of Washington, Seattle). Bootstrap analysis was performed with the programs Seqboot and Consense from the Phylip package. The Consense treefile was displayed with TreeView (32). Transmembrane helix predictions were performed with TMHMM version 2.0 at the Centralbureau voor Schimmelcultures (http://www.cbs.dtu.dk/services/TMHMM/) (19) and TMpred at EMBNET http://www.ch.embnet.org/software/TMPRED_form.html). Table 1 indicates the herpesvirus sequences used in the various analyses and their NCBI accession numbers. RESULTS Partial inverse PCR amplification of ORF 10 sequences from RFHVMm. We have previously used the CODEHOP technique, described in reference 35, to clone the entire DNA polymerase genes and flanking sequences of the macaque rhadinoviruses RFHVMn and RFHVMm (40). At present, this is the only information available regarding the genetic make-up of these viruses. We have had to rely on PCR amplification for the characterization of these viruses because of the minimal copy number of the viral genomes within the available tissue samples and the inability to culture the viruses in vitro. In an attempt to extend the sequences of these viral genomes into the region flanking the DNA polymerase gene, we initially employed a partial inverse PCR technique for cloning flanking sequences. Specific oligonucleotide primers, DRIPA and QIRQB, were derived from opposite strands of the DNA sequence at the 3′ end of the RFHVMm DNA polymerase gene, as shown in Fig. Fig.1.1 CODEHOP-based PCR amplification of sequences within the vTS genes of RFHVMm and RFHVMn. Although the inverse PCR technique resulted in new sequences flanking our original sequence, the amount of sequence was limited. Therefore, we pursued long-range amplification to obtain larger DNA fragments. Previous comparison of the nucleotide sequences of the DNA polymerase genes of KSHV and the two RFHV species suggested that the genomes of the macaque viruses would be similar to the KSHV genome (36, 40). Flanking the KSHV DNA polymerase gene is divergent locus B (DL-B), which contains a number of viral homologs of cellular genes that have been captured during the evolution of the virus (Fig. (Fig.1)1 Alignment of the available herpesvirus vTS homologs revealed the presence of two conserved amino acid motifs, RHFG and DMGL, which were separated by approximately 200 bp (data not shown). These motifs were chosen as CODEHOP targets, and RHFGA (sense orientation) and DMGLB (antisense orientation) CODEHOPs were derived from these motifs. Thermal gradient PCR amplification was performed with these CODEHOP primer pools with DNA isolated from retroperitoneal fibromatosis tissues from MmuYN-91 and Mne442N. Thermal gradient amplification empirically determines the optimal annealing temperature of CODEHOPs for amplification of unknown DNA templates by allowing multiple amplification reactions to proceed at different annealing temperatures. The PCR products obtained from amplification at different temperatures were analyzed by gel electrophoresis. An annealing temperature of ≈64.3°C (Fig. (Fig.2,2
Long-range PCR amplification of divergent locus B located between DNA polymerase and vTS genes of RFHVMm and RFHVMn. To characterize the DL-B region of the RFHVMm genome, gene-specific primers were derived from the ORF 10 sequence obtained by partial inverse PCR (primer F6565) and the TS sequence obtained by CODEHOP PCR (primer R20432) (see Fig. Fig.1).1 Long-range PCR amplification was performed on DNA from MmuYN-91 and Mne442N tissues containing RFHVMm and RFHVMn viral DNA, respectively. A single 3.6-kb PCR product was obtained from the MmuYN-91 retroperitoneal fibromatosis tissue with the ORF 10 and TS primers, while a 4.1-kb product was obtained from the Mne442N spleen tissue with the DNA polymerase and TS primers. The DNA sequences of these products were obtained and analyzed by Blast for similarities to known sequences. Five ORFs were identified downstream of the DNA polymerase gene in both the RFHVMm and RFHVMn PCR products (see Fig. Fig.3),3
Analysis of RFHV ORFs. (i) ORF 70 (vTS homolog). Blast analyses of the sequences obtained from the RFHVMn and RFHVMm long-range PCR products identified sequences homologous to the 3′ end of the KSHV vTS gene, which was designated ORF 70 because of homology with the HVS ORF 70 vTS gene (Fig. (Fig.3).3
Phylogenetic analysis of the TS sequence alignment in Fig. Fig.4A4A (ii) ORF 10 homolog. ORFs which encoded 411 amino acids that were 75% identical to each other and 46% identical to the KSHV ORF 10 were identified downstream of the DNA polymerase gene in the PCR fragments from RFHVMm and RFHVMn (Table 2). Blast (protein) analysis against the NCBI databases revealed similarities with the ORF 10 homologs of other gammaherpesviruses, including RRV (32% identity), HVS (23% identity), and Epstein-Barr virus (EBV) (12% identity, LF1 gene). Alignment of the amino acid sequences revealed the presence of numerous blocks of sequences conserved between the ORF 10 homologs of RFHVMn, RFHVMm, KSHV, and RRV (Fig. (Fig.5A).5A
A phylogenetic analysis was performed with the protein maximum-likelihood procedure, and a tree with an ln likelihood of −11551.56201 was obtained (Fig. (Fig.5B).5B To search for possible functional motifs, iterated searching of the nonredundant NCBI protein database with PSI-Blast was performed. While no obvious sequence similarity was detected between the RFHV ORF 10 and genes of known function, a similarity was detected with the ORF 11 sequences of KSHV, RRV, and other gammaherpesviruses. Figure Figure5A5A (iii) RFHV genome lacks an ORF 11 homolog. Downstream of ORF 10 in the KSHV genome is the 407-amino-acid ORF 11, which is homologous to the HVS ORF 11 and the EBV LF2 gene (37). ORF 11 homologs have been identified in analogous positions in all other gammaherpesviruses characterized except BHV4, which lacks a homologous ORF 11 gene (49). In our initial long-range PCR amplification studies, the PCR fragment obtained from RFHVMm was approximately 2 kb shorter than the fragment size predicted from the KSHV genome (Fig. (Fig.1).1 (iv) ORF RF2 homolog (vIL-6). Blast analysis of the sequences obtained from the long-range PCR products from RFHVMn and RFHVMm revealed the presence of a gene homologous to the ORF K2 gene of KSHV and the cellular cytokine IL-6. The ORF K2 gene has been identified previously as a viral homolog of IL-6 (vIL-6) (37). While the sequence similarity between the KSHV vIL6 and the cellular IL-6 is low (24%), the KSHV vIL-6 has been shown to have many biological functions in common with cellular IL-6 (29). Consistent with the naming convention used for the KSHV genome, we have designated the vIL-6 homolog of RFHV ORF RF2. ORF RF2 is similar in genomic location and orientation to the KSHV ORF K2 gene (Fig. (Fig.3).3 The amino acid sequences of the RFHV vIL-6 homologs were aligned with the vIL-6 homologs from KSHV and RRV and the cellular human and macaque IL-6 sequences. Only 12 of more than 200 amino acids (<6%) were conserved between the cellular and viral IL-6 homologs. However, examination of the alignment revealed significant sequence similarity between the vIL-6 homologs of RFHV and KSHV which did not extend to either the vIL-6 homolog of RRV or the human and macaque cellular IL-6 homologs (Fig. (Fig.6A).6A
(v) ORF 02 homolog (vDHFR). Dihydrofolate reductase (DHFR) is a ubiquitous protein in both prokaroytes and eukaryotes that is responsible for de novo synthesis of purines and deoxythymidine monophosphate for DNA synthesis. Viral homologs of DHFR have been identified in a restricted number of gammaherpesviruses within the genus Rhadinovirus, including KSHV (37), macaque RRV (42), and HVS from the New World squirrel monkey (44). As shown in Fig. Fig.3,3
(vi) ORF RF3 (MIR-1) homolog. ORFs encoding 233 and 232 amino acids were identified between the vDHFR and vTS genes of the RFHVMn and RFHVMm PCR fragments, respectively. A Blast similarity search demonstrated that these ORFs were closely related to the ORF K3 and K5 genes of KSHV. Because the RFHV ORFs were in a location identical to that of the K3 gene within the KSHV genome, they were designated ORF RF3 (see Fig. Fig.3).3 Alignment of the RFHVMn and RFHVMm RF3 genes with the other related sequences revealed a strong sequence similarity centered around a conserved cysteine and histidine motif within the N-terminal domain of these proteins. This motif belongs to the BKS (BHV4/KSHV/swinepox) subset of the C4HC3 PHD/LAP zinc finger motifs, as described before (31). The PHD/LAP motif family consists of a very general grouping of a number of proteins containing a C4HC3 motif, which has been implicated in DNA binding and chromatin-mediated transcriptional regulation (1, 38). A consensus sequence of highly conserved residues was determined for the BKS motif of RF3, K3, K5, Bo4, Bo5, and MK3 which consisted of C1-W-I-C2-X(2-4)-G-X(5-8)C3-X-C4-X-G-X4-V-H5-X2-C6-L-X2-W-X3-S-X4-C7-X2-C8-X3-Y. Whereas the domains containing the zinc finger motif (amino acids 9 to 53, Fig. Fig.8A)8A
Like the other viral homologs, the RF3 sequences contained two extended hydrophobic regions downstream of the zinc finger motif which were predicted to be membrane-spanning domains, as indicated in Fig. Fig.8A.8A Phylogenetic analysis of the RF3 homologs with several different methods, including neighbor-joining and protein maximum likelihood, revealed an obvious clustering of RF3, K3, and K5 (see Fig. Fig.8B)8B DISCUSSION We and others have previously reported that a number of Old World primate species are each host to two distinct RV-1 and RV-2 lineages of KSHV-like rhadinoviruses (13, 14, 20-22, 40). While the complete sequences have been determined for the genomes of human KSHV and macaque RRV, the classification of these and other KSHV-like rhadinoviruses into the RV-1 and RV-2 lineages of rhadinoviruses has been based solely on comparison of DNA polymerase sequences. Sequence analysis of the complete genomes of KSHV and RRV has revealed numerous similarities in gene structure and content which support a close evolutionary relationship (11). However, the genetic content of these viruses is not identical, with numerous examples of genes which are present in one virus and absent in the other (42). It has not been clear whether these differences are simply because of speciation of the human and macaque viruses or whether they reflect important structural and functional properties of the two distinct viral lineages. Identification of genetic properties unique to the RV-1 and RV-2 rhadinovirus lineages has been hampered by the absence of an identified RV-2 rhadinovirus from a human host and the difficulty in obtaining further genomic sequence from the other identified RV-1 rhadinoviruses from nonhuman hosts. Among the identified nonhuman RV-1 rhadinoviruses, the greatest amount of sequence information has been obtained for RFHV, the putative macaque RV-1 rhadinovirus, with sequence covering the entire DNA polymerase gene and flanking sequences. However, there has still been some uncertainty concerning the exact nature of the relationship between RFHV and the other macaque virus, RRV, because of the relatively small amount of sequence data and information on gene content available for RFHV. In the present study, we have added to the amount of available RFHV genetic information by determining 4.3 kb of contiguous sequence within the DL-B region of the RFHVMm and RFHVMn genomes. These sequences overlap the DNA polymerase sequences obtained previously (36, 40), extending the available sequence for both RFHV species to approximately 7.7 kb. Within this 7.7-kb genomic region, open reading frames encoding homologs of the KSHV glycoprotein B, DNA polymerase, ORF 10, vIL-6, vDHFR, ORF K3/MIR-1, and vTS genes were identified. These genes were present in the same order and relative positions as in the KSHV genome (37). However, unlike KSHV, the RFHVMn and RFHVMm genomes lacked an ORF 11 homolog. Blast comparisons and phylogenetic analysis of each RFHVMn and RFHVMm ORF demonstrated the closest similarity to the corresponding ORF within the KSHV genome. These results strongly support the grouping of RFHV with KSHV within the RV-1 rhadinovirus lineage and provide evidence that RFHVMm and RFHVMn are the rhesus and pig-tailed macaque homologs of KSHV. Comparison of the macaque RFHV and RRV genomes within the region of the DL-B targeted in this study revealed important differences in the colinear organization and genetic content of the genomes. One such difference was the presence of the RF3 homolog of MIR-1/ORF K3 in RFHV which was absent from RRV. MIR-1 homologs have been identified in other herpesviruses, including BHV4, MHV68, and HVS, and in several poxviruses, including swinepox and myxoma virus (31, 46). MIR-1 and the closely related MIR-2 of KSHV, ORF MK3 of MHV68, and the MV-LAP protein of myxoma virus have been shown to function in immune evasion through downregulation of members of major histocompatibility complex class I (MHC-I) and other molecules involved in immune recognition (8, 9, 15, 16, 48). For this reason, the KSHV proteins have been termed modulators of immune response (MIR), while the MV-LAP protein have been described as endoplasmic reticulum-resident surface cellular receptor abductor proteins, called scrapins (15). MIR-1 and MIR-2 function as membrane-bound E3 ubiquitin ligases which ubiquitinate the cytosolic tail of immune recognition proteins, targeting them for endolysosomal degradation (10, 25). The ability to impair host cytotoxic T-lymphocyte recognition of virus-infected cells is believed to be an important factor in the viral persistence characteristic of KSHV and other herpesviruses. The presence of the RF3 MIR homolog in RFHV and its absence in RRV demonstrates for the first time a clear difference between the genetic repertoire of the two distinct lineages of KSHV-like macaque rhadinoviruses and suggests either that the persistence of RRV in infected cells is different from that seen with RFHV and KSHV or that RRV employs another means of enhancing viral persistence. Further analysis of the genomes of the other RV-1 Old World primate rhadinoviruses will determine whether this genetic feature is characteristic of the RV-1 lineage in general. In addition to the conservation within the BKS zinc finger domain of the MIR homologs, sequence similarity was detected within the C-terminal conserved region (CR) domains of RF3, MIR-1, and MIR-2 (Fig. (Fig.8A).8A Only the RF3 transmembrane regions from RFHVMn and RFHVMm were well conserved between each other, with 95% amino acid identity between amino acids 80 and 145. Replacement studies have shown that the transmembrane domains are responsible for the target specificity of MIR activity (39). Thus, the close similarity between the RF3 homologs of RFHVMn and RFHVMm might reflect target similarities within the two macaque species, while the differences between the RF3 and MIR transmembrane domains could reflect the different specificities required for interactions with macaque and human immune proteins. Experiments are under way to examine the ubiquitin ligase activity and target specificity of macaque RF3. Other differences in the genome structures of RFHV and RRV were also evident from our analysis of the DL-B region. Whereas the genomes of both RFHV and KSHV contain a vDHFR gene immediately to the left and downstream of the RF3/K3 homolog, the RRV vDHFR is positioned at the far left end of the viral genome. The positioning of the RRV vDHFR gene is similar to that seen in the New World primate rhadinovirus HVS (see Fig. Fig.3).3 Our studies show that RFHV, like KSHV and RRV, contains a viral homolog of the cellular IL-6 in a conserved orientation within the DL-B region. Of all the herpesviruses identified to date, only these KSHV-like rhadinoviruses contain a vIL6 homolog (31, 37). While our studies show that the IL-6 homologs of RFHV and KSHV have a conserved gene structure and sequence, the RRV vIL-6 has diverged considerably, with substantial changes in amino acid sequence and three internal insertions or deletions with respect to the other vIL-6 and cellular IL-6 homologs. These structural differences suggest the possibility of functional differences. Cellular IL-6 is one of a family of related cytokines which has been implicated in the pathogenesis of several B-cell neoplasias (18), and the presence of a vIL6 homolog in KSHV suggests a potential role for this protein in the induction and progression of Kaposi's sarcoma and the B-cell neoplasias associated with KSHV. Whereas cellular IL-6 requires the presence of the nonsignaling receptor subunit (IL-6R) and the signaling receptor subunit gp130 for signal transduction, the KSHV vIL-6 can interact and signal directly through the ubiquitous gp130 receptor subunit in the absence of IL-6R (28). Recent results suggest that the gp130-specific signaling by KSHV vIL-6 plays an important role in bypassing the antiviral effects of interferon (6). Crystallographic studies of the KSHV vIL6-gp130 extracellular receptor complex have identified major sites of protein interaction which are primarily hydrophobic (7). The site II interface of KSHV vIL-6 is dominated by Trp41, Trp44, and Trp134, while the site III interface is dominated by Leu165, Tyr166, Trp167, and Phe171. These interactions are predicted to allow two molecules of vIL-6 to bind to two gp130 subunits in the absence of the IL-6R subunit. Most of these residues are conserved within the RFHVMn and RFHVMm vIL-6 homologs, suggesting similarities in receptor binding (Fig. (Fig.6A6A Interestingly, very few of these hydrophobic residues are conserved within the RRV vIL-6. In RRV, Trp41 is replaced by a negatively charged glutamic acid and Trp167 is replaced by a positively charged arginine. This is similar to the situation with the cellular IL-6 homologs, which lack the conserved hydrophobic residues in the site II and site III domains and instead have small polar residues in these positions. The lack of hydrophobic residues available for site II and III binding suggests that, like cellular IL-6, RRV vIL-6 may not bind and signal directly through interactions with gp130, but instead could require the presence of the IL-6R subunit. Studies with RRV vIL-6 support this hypothesis. Antibodies directed against the IL-6R subunit completely inhibit RRV vIL-6-induced proliferation of B9 mouse cells (17). This contrasts with the situation with KSHV vIL-6, where antibodies against gp130 inhibited vIL-6 activity while antibodies against IL-6R did not (5, 28). These results suggest that the vIL-6 homologs from members of the RV-1 lineage of rhadinoviruses could exert their biological effect on any cell which expresses a sufficient quantity of the gp130 signaling receptor, whereas the effects of vIL-6 homologs from members of the RV-2 lineage of rhadinoviruses would be limited to cells expressing both the IL-6R nonsignaling subunit and the gp130 signaling subunit. We are currently examining the receptor binding properties of the two macaque vIL6 homologs. Our results demonstrate that RFHV contains a vTS homolog in a genomic position and orientation similar to those of the vTS homologs of the other Old World primate rhadinoviruses KSHV and RRV. This contrast with the position of the vTS homologs within the genomes of the New World primate rhadinoviruses HVS and ateline herpesvirus 3 and the ungulate rhadinovirus EHV2, in which the vTS genes are located much further downstream at the right end of the genome (2, 3, 43). While TS homologs are also present in the human and simian varicella-zoster virus homologs (as shown in Fig. 4A and B In contrast to KSHV and RRV, RFHV lacks an ORF 11 homolog downstream of ORF 10. This was confirmed by sequencing this region in both RFHVMn and RFHVMm species. Although the presence of an ORF 11 homolog is a conserved feature within most gammaherpesviruses, the ungulate rhadinovirus BHV4 also lacks an ORF 11 homolog (49). Analysis of the ORF 11 homologs of other gammaherpesviruses with repetitive PSI-Blast searches of the NCBI databases revealed a distant similarity to the gammaherpesvirus ORF 10 homologs (see alignment in Fig. Fig.5A).5A Our studies demonstrate a strong similarity in sequence conservation, genetic complement, and colinear organization of genes within the DL-B region of the genomes of macaque RFHV and human KSHV. These findings strongly support the hypothesis that RFHV is the macaque equivalent of KSHV and substantiate the grouping of these viruses together within the RV-1 lineage of Old World primate rhadinoviruses. Conversely, the differences detected between the sequence conservation, genetic complement, and colinear organization of the macaque RFHV and RRV genomes support the grouping of these two macaque viruses into distinct RV-1 and RV-2 rhadinovirus lineages, respectively. However, the ultimate comparison of these macaque rhadinoviruses awaits the complete sequencing of the RFHV genome. Even though the RV-1 and RV-2 lineages of rhadinoviruses are more closely related to each other than to other members of the Herpesviridae, our findings suggest that the two macaque rhadinovirus lineages have diverged considerably over time, yielding differences in gene content, organization, and structure that would provide the basis for biological differences between the members of these two viral lineages. No evidence of interlineage recombination between the macaque RV-1 and RV-2 rhadinoviruses was detected, even though mixed infections were identified in numerous individual macaques. Acknowledgments This work was supported by grants to T. M. Rose from the National Institutes of Health (R55-CA72237 and RO1-RR13154). T. M. Rose was the recipient of an Independent Scientist Award, K02-AI49275. We acknowledge Riri Shibata and Harold McClure for generous gifts of tissue samples and Greg Bruce and Jacques Garrigues for helpful advice and discussion. We also thank John Nicolas for providing unpublished information concerning the structure of KSHV during the initiation of this research. REFERENCES 1. Aasland, R., T. J. Gibson, and A. F. Stewart. 1995. The PHD finger: implications for chromatin-mediated transcriptional regulation. Trends Biochem. Sci. 20:56-59. [PubMed] 2. Albrecht, J. C. 2000. Primary structure of the herpesvirus ateles genome. J. Virol. 74:1033-1037. [PubMed] 3. Albrecht, J. C., J. Nicholas, D. Biller, K. R. Cameron, B. Biesinger, C. Newman, S. Wittmann, M. A. Craxton, H. Coleman, B. Fleckenstein, et al. 1992. Primary structure of the herpesvirus saimiri genome. J. Virol. 66:5047-5058. [PubMed] 4. Auerbach, M. R., S. C. Czajak, W. E. Johnson, R. C. Desrosiers, and L. Alexander. 2000. Species specificity of macaque rhadinovirus glycoprotein B sequences. J. Virol. 74:584-590. [PubMed] 5. Burger, R., F. Neipel, B. Fleckenstein, R. Savino, G. Ciliberto, J. R. Kalden, and M. Gramatzki. 1998. Human herpesvirus type 8 interleukin-6 homologue is functionally active on human myeloma cells. Blood 91:1858-1863. [PubMed] 6. Chatterjee, M., J. Osborne, G. Bestetti, Y. Chang, and P. S. Moore. 2002. Viral IL-6-induced cell proliferation and immune evasion of interferon activity. Science 298:1432-1435. [PubMed] 7. Chow, D., X. He, A. L. Snow, S. Rose-John, and K. C. Garcia. 2001. Structure of an extracellular gp130 cytokine receptor signaling complex. Science 291:2150-2155. [PubMed] 8. Coscoy, L., and D. Ganem. 2000. Kaposi's sarcoma-associated herpesvirus encodes two proteins that block cell surface display of MHC class I chains by enhancing their endocytosis. Proc. Natl. Acad. Sci. USA 97:8051-8056. [PubMed] 9. Coscoy, L., and D. Ganem. 2001. A viral protein that selectively downregulates ICAM-1 and B7-2 and modulates T cell costimulation. J. Clin. Investig. 107:1599-1606. [PubMed] 10. Coscoy, L., D. J. Sanchez, and D. Ganem. 2001. A novel class of herpesvirus-encoded membrane-bound E3 ubiquitin ligases regulates endocytosis of proteins involved in immune recognition. J. Cell Biol. 155:1265-1273. [PubMed] 11. Desrosiers, R. C., V. G. Sasseville, S. C. Czajak, X. Zhang, K. G. Mansfield, A. Kaur, R. P. Johnson, A. A. Lackner, and J. U. Jung. 1997. A herpesvirus of rhesus monkeys related to the human Kaposi's sarcoma-associated herpesvirus. J. Virol. 71:9764-9769. [PubMed] 12. Giddens, W. E., Jr., C. C. Tsai, W. R. Morton, H. D. Ochs, G. H. Knitter, and G. A. Blakley. 1985. Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques. Pathologic observations and transmission studies. Am. J. Pathol. 119:253-263. [PubMed] 13. Greensill, J., and T. F. Schulz. 2000. Rhadinoviruses (gamma2-herpesviruses) of Old World primates: models for KSHV/HHV8-associated disease? AIDS 14:S11-S19. 14. Greensill, J., J. A. Sheldon, N. M. Renwick, B. E. Beer, S. Norley, J. Goudsmit, and T. F. Schulz. 2000. Two distinct gamma-2 herpesviruses in African green monkeys: a second gamma-2 herpesvirus lineage among Old World primates? J. Virol. 74:1572-1577. [PubMed] 15. Guerin, J. L., J. Gelfi, S. Boullier, M. Delverdier, F. A. Bellanger, S. Bertagnoli, I. Drexler, G. Sutter, and F. Messud-Petit. 2002. Myxoma virus leukemia-associated protein is responsible for major histocompatibility complex class I and Fas-CD95 down-regulation and defines scrapins, a new group of surface cellular receptor abductor proteins. J Virol. 76:2912-2923. [PubMed] 16. Ishido, S., C. Wang, B. S. Lee, G. B. Cohen, and J. U. Jung. 2000. Downregulation of major histocompatibility complex class I molecules by Kaposi's sarcoma-associated herpesvirus K3 and K5 proteins. J. Virol. 74:5300-5309. [PubMed] 17. Kaleeba, J. A., E. P. Bergquam, and S. W. Wong. 1999. A rhesus macaque rhadinovirus related to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 encodes a functional homologue of interleukin-6. J. Virol. 73:6177-6181. [PubMed] 18. Kishimoto, T., S. Akira, M. Narazaki, and T. Taga. 1995. Interleukin-6 family of cytokines and gp130. Blood 86:1243-1254. [PubMed] 19. Krogh, A., B. Larsson, G. von Heijne, and E. L. Sonnhammer. 2001. Predicting transmembrane protein topology with a hidden Markov model: application to complete genomes. J. Mol. Biol. 305:567-580. [PubMed] 20. Lacoste, V., P. Mauclere, G. Dubreuil, J. Lewis, M. C. Georges-Courbot, and A. Gessain. 2000. KSHV-like herpesviruses in chimps and gorillas. Nature 407:151-152. [PubMed] 21. Lacoste, V., P. Mauclere, G. Dubreuil, J. Lewis, M. C. Georges-Courbot, and A. Gessain. 2001. A novel gamma 2-herpesvirus of the rhadinovirus 2 lineage in chimpanzees. Genome Res. 11:1511-1519. [PubMed] 22. Lacoste, V., P. Mauclere, G. Dubreuil, J. Lewis, M. C. Georges-Courbot, J. Rigoulet, T. Petit, and A. Gessain. 2000. Simian homologues of human gamma-2 and betaherpesviruses in mandrill and drill monkeys. J. Virol. 74:11993-11999. [PubMed] 23. Li, H., H. Wang, and J. Nicholas. 2001. Detection of direct binding of human herpesvirus 8-encoded interleukin-6 (vIL-6) to both gp130 and IL-6 receptor (IL-6R) and identification of amino acid residues of vIL-6 important for IL-6R-dependent and -independent signaling. J. Virol. 75:3325-3334. [PubMed] 24. Lisitsyn, N., and M. Wigler. 1993. Cloning the differences between two complex genomes. Science 259:946-951. [PubMed] 25. Lorenzo, M. E., J. U. Jung, and H. L. Ploegh. 2002. Kaposi's sarcoma-associated herpesvirus K3 utilizes the ubiquitin-proteasome system in routing class major histocompatibility complexes to late endocytic compartments. J. Virol. 76:5522-5531. [PubMed] 26. Mansfield, K. G., S. V. Westmoreland, C. D. DeBakker, S. Czajak, A. A. Lackner, and R. C. Desrosiers. 1999. Experimental infection of rhesus and pig-tailed macaques with macaque rhadinoviruses. J. Virol. 73:10320-10328. [PubMed] 27. McGeoch, D. J. 2001. Molecular evolution of the gamma-Herpesvirinae. Phil. Trans. R. Soc. Lond. B Biol. Sci. 356:421-435. [PubMed] 28. Molden, J., Y. Chang, Y. You, P. S. Moore, and M. A. Goldsmith. 1997. A Kaposi's sarcoma-associated herpesvirus-encoded cytokine homolog (vIL-6) activates signaling through the shared gp130 receptor subunit. J. Biol. Chem. 272:19625-19631. [PubMed] 29. Moore, P. S., and Y. Chang. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Phil. Trans. R. Soc. Lond. B Biol. Sci. 356:499-516. [PubMed] 30. Moore, P. S., S. J. Gao, G. Dominguez, E. Cesarman, O. Lungu, D. M. Knowles, R. Garber, P. E. Pellett, D. J. McGeoch, and Y. Chang. 1996. Primary characterization of a herpesvirus agent associated with Kaposi's sarcoma. J. Virol. 70:549-558. (Erratum, J. Virol. 70:9083.) [PubMed] 31. Nicholas, J., V. Ruvolo, J. Zong, D. Ciufo, H. G. Guo, M. S. Reitz, and G. S. Hayward. 1997. A single 13-kilobase divergent locus in the Kaposi sarcoma-associated herpesvirus (human herpesvirus 8) genome contains nine open reading frames that are homologous to or related to cellular proteins. J. Virol. 71:1963-1974. [PubMed] 32. Page, R. D. 1996. TreeView: an application to display phylogenetic trees on personal computers. Comput. Appl. Biosci. 12:357-358. [PubMed] 33. Pang, K. M., and D. A. Knecht. 1997. Partial inverse PCR: a technique for cloning flanking sequences. BioTechniques 22:1046-1048. [PubMed] 34. Parker, B. D., A. Bankier, S. Satchwell, B. Barrell, and P. J. Farrell. 1990. Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region. Virology 179:339-346. [PubMed] 35. Rose, T. M., E. R. Schultz, J. G. Henikoff, S. Pietrokovski, C. M. McCallum, and S. Henikoff. 1998. Consensus-degenerate hybrid oligonucleotide primers for amplification of distantly related sequences. Nucleic Acids Res. 26:1628-1635. [PubMed] 36. Rose, T. M., K. B. Strand, E. R. Schultz, G. Schaefer, G. W. Rankin, Jr., M. E. Thouless, C. C. Tsai, and M. L. Bosch. 1997. Identification of two homologs of the Kaposi's sarcoma-associated herpesvirus (human herpesvirus 8) in retroperitoneal fibromatosis of different macaque species. J. Virol. 71:4138-4144. [PubMed] 37. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc. Natl. Acad. Sci. USA 93:14862-14867. [PubMed] 38. Saha, V., T. Chaplin, A. Gregorini, P. Ayton, and B. D. Young. 1995. The leukemia-associated-protein (LAP) domain, a cysteine-rich motif, is present in a wide range of proteins, including MLL, AF10, and MLLT6 proteins. Proc. Natl. Acad. Sci. USA 92:9737-9741. [PubMed] 39. Sanchez, D. J., L. Coscoy, and D. Ganem. 2002. Functional organization of MIR-2, a novel viral regulator of selective endocytosis. J. Biol. Chem. 277:6124-6130. [PubMed] 40. Schultz, E. R., G. W. Rankin, Jr., M. P. Blanc, B. W. Raden, C. C. Tsai, and T. M. Rose. 2000. Characterization of two divergent lineages of macaque rhadinoviruses related to Kaposi's sarcoma-associated herpesvirus. J. Virol. 74:4919-4928. [PubMed] 41. Schulz, T. F., and P. S. Moore. 1999. Kaposi's sarcoma-associated herpesvirus: a new human tumor virus, but how? Trends Microbiol. 7:196-200. [PubMed] 42. Searles, R. P., E. P. Bergquam, M. K. Axthelm, and S. W. Wong. 1999. Sequence and genomic analysis of a rhesus macaque rhadinovirus with similarity to Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8. J. Virol. 73:3040-3053. [PubMed] 43. Telford, E. A., M. S. Watson, H. C. Aird, J. Perry, and A. J. Davison. 1995. The DNA sequence of equine herpesvirus 2. J. Mol. Biol. 249:520-528. [PubMed] 44. Trimble, J. J., S. C. Murthy, A. Bakker, R. Grassmann, and R. C. Desrosiers. 1988. A gene for dihydrofolate reductase in a herpesvirus. Science 239:1145-1147. [PubMed] 45. Tsai, C. C., W. E. Giddens, Jr., H. D. Ochs, W. R. Morton, G. H. Knitter, G. A. Blakley, and R. E. Benveniste. 1986. Retroperitoneal fibromatosis and acquired immunodeficiency syndrome in macaques: clinical and immunologic studies. Lab. Anim. Sci. 36:119-125. [PubMed] 46. Virgin, H. W. t., P. Latreille, P. Wamsley, K. Hallsworth, K. E. Weck, A. J. Dal Canto, and S. H. Speck. 1997. Complete sequence and genomic analysis of murine gammaherpesvirus 68. J. Virol. 71:5894-5904. [PubMed] 47. Xu, G. Y., H. A. Yu, J. Hong, M. Stahl, T. McDonagh, L. E. Kay, and D. A. Cumming. 1997. Solution structure of recombinant human interleukin-6. J. Mol. Biol. 268:468-481. [PubMed] 48. Yu, Y. Y., M. R. Harris, L. Lybarger, L. A. Kimpler, N. B. Myers, H. W. t. Virgin, and T. H. Hansen. 2002. Physical association of the K3 protein of gamma-2 herpesvirus 68 with major histocompatibility complex class I molecules with impaired peptide and beta2-microglobulin assembly. J. Virol. 76:2796-2803. [PubMed] 49. Zimmermann, W., H. Broll, B. Ehlers, H. J. Buhk, A. Rosenthal, and M. Goltz. 2001. Genome sequence of bovine herpesvirus 4, a bovine rhadinovirus, and identification of an origin of DNA replication. J. Virol. 75:1186-1194. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||||||||
Trends Microbiol. 1999 May; 7(5):196-200.
[Trends Microbiol. 1999]J Virol. 1996 Jan; 70(1):549-58.
[J Virol. 1996]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29; 356(1408):499-516.
[Philos Trans R Soc Lond B Biol Sci. 2001]J Virol. 1997 May; 71(5):4138-44.
[J Virol. 1997]Am J Pathol. 1985 May; 119(2):253-63.
[Am J Pathol. 1985]Lab Anim Sci. 1986 Apr; 36(2):119-25.
[Lab Anim Sci. 1986]Nucleic Acids Res. 1998 Apr 1; 26(7):1628-35.
[Nucleic Acids Res. 1998]J Virol. 1997 Dec; 71(12):9764-9.
[J Virol. 1997]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]J Virol. 2000 Feb; 74(3):1572-7.
[J Virol. 2000]Nature. 2000 Sep 14; 407(6801):151-2.
[Nature. 2000]J Virol. 2000 Dec; 74(24):11993-9.
[J Virol. 2000]J Cell Biol. 2001 Dec 24; 155(7):1265-73.
[J Cell Biol. 2001]Biotechniques. 1997 Jun; 22(6):1046-8.
[Biotechniques. 1997]Nucleic Acids Res. 1998 Apr 1; 26(7):1628-35.
[Nucleic Acids Res. 1998]Science. 1993 Feb 12; 259(5097):946-51.
[Science. 1993]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]Comput Appl Biosci. 1996 Aug; 12(4):357-8.
[Comput Appl Biosci. 1996]J Mol Biol. 2001 Jan 19; 305(3):567-80.
[J Mol Biol. 2001]Nucleic Acids Res. 1998 Apr 1; 26(7):1628-35.
[Nucleic Acids Res. 1998]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]Biotechniques. 1997 Jun; 22(6):1046-8.
[Biotechniques. 1997]J Virol. 1997 May; 71(5):4138-44.
[J Virol. 1997]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]J Virol. 1997 Mar; 71(3):1963-74.
[J Virol. 1997]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]J Virol. 2001 Feb; 75(3):1186-94.
[J Virol. 2001]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29; 356(1408):499-516.
[Philos Trans R Soc Lond B Biol Sci. 2001]J Virol. 1997 Dec; 71(12):9764-9.
[J Virol. 1997]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]J Virol. 1999 Apr; 73(4):3040-53.
[J Virol. 1999]Science. 1988 Mar 4; 239(4844):1145-7.
[Science. 1988]J Virol. 1997 Mar; 71(3):1963-74.
[J Virol. 1997]Trends Biochem Sci. 1995 Feb; 20(2):56-9.
[Trends Biochem Sci. 1995]Proc Natl Acad Sci U S A. 1995 Oct 10; 92(21):9737-41.
[Proc Natl Acad Sci U S A. 1995]J Virol. 2000 Feb; 74(3):1572-7.
[J Virol. 2000]Nature. 2000 Sep 14; 407(6801):151-2.
[Nature. 2000]J Virol. 2000 Dec; 74(24):11993-9.
[J Virol. 2000]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]J Virol. 1997 Dec; 71(12):9764-9.
[J Virol. 1997]J Virol. 1997 May; 71(5):4138-44.
[J Virol. 1997]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]J Virol. 1997 Mar; 71(3):1963-74.
[J Virol. 1997]J Virol. 1997 Aug; 71(8):5894-904.
[J Virol. 1997]Proc Natl Acad Sci U S A. 2000 Jul 5; 97(14):8051-6.
[Proc Natl Acad Sci U S A. 2000]J Clin Invest. 2001 Jun; 107(12):1599-606.
[J Clin Invest. 2001]J Virol. 2002 Mar; 76(6):2912-23.
[J Virol. 2002]J Cell Biol. 2001 Dec 24; 155(7):1265-73.
[J Cell Biol. 2001]J Virol. 2002 Jun; 76(11):5522-31.
[J Virol. 2002]J Biol Chem. 2002 Feb 22; 277(8):6124-30.
[J Biol Chem. 2002]J Biol Chem. 2002 Feb 22; 277(8):6124-30.
[J Biol Chem. 2002]J Virol. 1997 Mar; 71(3):1963-74.
[J Virol. 1997]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]Blood. 1995 Aug 15; 86(4):1243-54.
[Blood. 1995]J Biol Chem. 1997 Aug 1; 272(31):19625-31.
[J Biol Chem. 1997]Science. 2002 Nov 15; 298(5597):1432-5.
[Science. 2002]Science. 2001 Mar 16; 291(5511):2150-5.
[Science. 2001]J Virol. 1999 Jul; 73(7):6177-81.
[J Virol. 1999]Blood. 1998 Mar 15; 91(6):1858-63.
[Blood. 1998]J Biol Chem. 1997 Aug 1; 272(31):19625-31.
[J Biol Chem. 1997]J Virol. 2000 Jan; 74(2):1033-7.
[J Virol. 2000]J Virol. 1992 Aug; 66(8):5047-58.
[J Virol. 1992]J Mol Biol. 1995 Jun 9; 249(3):520-8.
[J Mol Biol. 1995]Philos Trans R Soc Lond B Biol Sci. 2001 Apr 29; 356(1408):421-35.
[Philos Trans R Soc Lond B Biol Sci. 2001]J Virol. 2001 Feb; 75(3):1186-94.
[J Virol. 2001]Virology. 1990 Nov; 179(1):339-46.
[Virology. 1990]J Virol. 2000 Jan; 74(2):1033-7.
[J Virol. 2000]J Virol. 2000 May; 74(10):4919-28.
[J Virol. 2000]J Mol Biol. 1997 May 2; 268(2):468-81.
[J Mol Biol. 1997]Science. 2001 Mar 16; 291(5511):2150-5.
[Science. 2001]J Virol. 2001 Apr; 75(7):3325-34.
[J Virol. 2001]Proc Natl Acad Sci U S A. 1996 Dec 10; 93(25):14862-7.
[Proc Natl Acad Sci U S A. 1996]